These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20862601)

  • 1. Defining scaffold geometries for interacting with proteins: geometrical classification of secondary structure linking regions.
    Tran TT; Kulis C; Long SM; Bryant D; Adams P; Smythe ML
    J Comput Aided Mol Des; 2010 Nov; 24(11):917-34. PubMed ID: 20862601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological side-chain classification of beta-turns: ideal motifs for peptidomimetic development.
    Tran TT; McKie J; Meutermans WD; Bourne GT; Andrews PR; Smythe ML
    J Comput Aided Mol Des; 2005 Aug; 19(8):551-66. PubMed ID: 16328857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping side chain interactions at protein helix termini.
    Newell NE
    BMC Bioinformatics; 2015 Jul; 16():231. PubMed ID: 26209176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23.
    Barkan DT; Cheng XL; Celino H; Tran TT; Bhandari A; Craik CS; Sali A; Smythe ML
    BMC Bioinformatics; 2016 Nov; 17(1):481. PubMed ID: 27881076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Privileged scaffolds targeting reverse-turn and helix recognition.
    Che Y; Marshall GR
    Expert Opin Ther Targets; 2008 Jan; 12(1):101-14. PubMed ID: 18076374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics.
    Ruiz-Gómez G; Hawkins JC; Philipp J; Künze G; Wodtke R; Löser R; Fahmy K; Pisabarro MT
    PLoS One; 2016; 11(4):e0154046. PubMed ID: 27123592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology.
    Gentilucci L; Cardillo G; Tolomelli A; Squassabia F; Tiozzo C
    Med Chem; 2006 Jul; 2(4):395-400. PubMed ID: 16848752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta-D-glucose scaffold as a beta-turn mimetic.
    Hirschmann RF; Nicolaou KC; Angeles AR; Chen JS; Smith AB
    Acc Chem Res; 2009 Oct; 42(10):1511-20. PubMed ID: 19624154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Exploration of Molecular Scaffolds in Medicinal Chemistry.
    Hu Y; Stumpfe D; Bajorath J
    J Med Chem; 2016 May; 59(9):4062-76. PubMed ID: 26840095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeepCubist: Molecular Generator for Designing Peptidomimetics based on Complex three-dimensional scaffolds.
    Umedera K; Yoshimori A; Chen H; Kouji H; Nakamura H; Bajorath J
    J Comput Aided Mol Des; 2023 Feb; 37(2):107-115. PubMed ID: 36462089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Bioactive Scaffolds Based on QSAR Models.
    Nakagawa T; Miyao T; Funatsu K
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases.
    Stahura FL; Xue L; Godden JW; Bajorath J
    J Mol Graph Model; 1999 Feb; 17(1):1-9, 51-2. PubMed ID: 10660905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of scaffold-hopping approaches.
    Sun H; Tawa G; Wallqvist A
    Drug Discov Today; 2012 Apr; 17(7-8):310-24. PubMed ID: 22056715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting Assumptions in the Design of Peptidomimetics.
    Marshall GR; Ballante F
    Drug Dev Res; 2017 Sep; 78(6):245-267. PubMed ID: 28875546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple yet functional phosphate-loop proteins.
    Romero Romero ML; Yang F; Lin YR; Toth-Petroczy A; Berezovsky IN; Goncearenco A; Yang W; Wellner A; Kumar-Deshmukh F; Sharon M; Baker D; Varani G; Tawfik DS
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11943-E11950. PubMed ID: 30504143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Privileged scaffolds in lead generation.
    Zhao H; Dietrich J
    Expert Opin Drug Discov; 2015 Jul; 10(7):781-90. PubMed ID: 25959748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An α-helical peptidomimetic scaffold for dynamic combinatorial library formation.
    Busschaert N; Thompson S; Hamilton AD
    Chem Commun (Camb); 2016 Dec; 53(2):313-316. PubMed ID: 27892554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines.
    Zerbe K; Moehle K; Robinson JA
    Acc Chem Res; 2017 Jun; 50(6):1323-1331. PubMed ID: 28570824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.